Cells (8 × 105) were seeded into 60-mm dishes. For both pERK1/2 and pMLC (Phospho-Myosin Light Chain 2, Thr18/Ser19) immunoblots, cells were harvested 24 h after seeding by direct lysis in 2× Laemmli buffer mixed with equal volume of RIPA buffer (10 mM Tris-Cl pH 8.0, 1 mM EDTA, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS, 140 mM NaCl, protease/phosphatase inhibitor cocktail Thermo Fisher, Waltham, MA, USA, cat#88266). Samples were sonicated 2× for 5 s and heated for 5 min at 95 °C. Equal volumes of protein lysate (30 µL) for each cell line were resolved using 15% SDS-PAGE gels, transferred to PVDF membranes, and blocked in 5% BSA in Tween tris-buffered saline. Primary and secondary antibodies were diluted in 1% BSA and 0.01% Triton X-100 in PBS. Membranes were incubated in 1:1000 diluted primary antibodies pERK1/2 pT202/Y204 (Calbiochem, Burlington, MA, USA cat# KP26001), total ERK1/2 (Cell Signaling, Danvers, MA, USA, cat# 9102), pMLC (Cell Signaling, cat# 3674S), and GAPDH (Santa Cruz, cat#365062) overnight at 4 °C. HRP-conjugated anti-rabbit (Cell Signaling, cat# 7074P2), and HRP-conjugated anti-mouse (Cell Signaling, cat# 7076P2) antibodies were diluted 1:6000. Blots were developed using FemtoGlow™ Western chemiluminescent HRP substrate (Michigan Diagnostics, Royal Oak, MI, USA, cat# FWPS02). Bands were visualized and quantified using a Li-Cor Odyssey Fc scanner and quantified using Image Studio Lite Version 5.2. The full western blots were shown in Figures S4 and S5.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.